Related Experiment Video
Updated: Apr 5, 2026
07:37
Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
14.3K
Interferon-γ: Promising therapeutic target in atherosclerosis
1Joe WE Moss, Dipak P Ramji, Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3AX, United Kingdom.
World Journal of Experimental Medicine
|August 27, 2015
Summary
Atherosclerosis, a vascular inflammatory disease, persists despite statin therapy. Interferon-gamma (IFN-γ) drives atherosclerosis progression, presenting a potential therapeutic target for cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Immunology
- Molecular Biology
Background:
- Atherosclerosis is a leading cause of global mortality, characterized by chronic vascular inflammation.
- Cardiovascular disease (CVD) risk factors like diabetes and obesity are increasing worldwide.
- Statins reduce CVD mortality, yet residual risk necessitates novel therapeutic strategies.
Purpose of the Study:
- To elucidate the critical role of Interferon-gamma (IFN-γ) in atherosclerosis pathogenesis.
- To explore therapeutic strategies targeting IFN-γ for atherosclerosis treatment.
Main Methods:
- This editorial reviews existing literature on IFN-γ's function in vascular inflammation.
- Analysis of IFN-γ's influence on gene expression, monocyte recruitment, and plaque stability.
Main Results:
- IFN-γ acts as a master regulator in atherosclerosis development.
- IFN-γ modulates pro-inflammatory gene expression and monocyte adhesion to endothelium.
- IFN-γ impacts atherosclerotic plaque stability.
Conclusions:
- IFN-γ is a key molecular driver of atherosclerosis.
- Targeting IFN-γ offers a promising therapeutic avenue for managing residual CVD risk.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
32
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32
01:26Atherosclerosis III: Management
589
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
01:30Atherosclerosis I: Introduction
2.0K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
01:23Atherosclerosis IV: Nursing Management
574
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
574
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
754
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
754
01:29Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86